Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

431696

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research his Department has conducted on the disincentives to prescribing off-patent repurposed drugs.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	17150
answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The Department has conducted no such research. Current arrangements already allow off-patent drugs to be prescribed for new purposes where this is the most appropriate clinical treatment course for a patient. Prescribing decisions are a matter for the clinical judgement of the prescriber concerned.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:49:32 answering member 4020 label Biography information for George Freeman
tabling member	4443 label Biography information for Carol Monaghan

431700

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Off-patent Drugs Bill
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the contribution of 6 November 2015 by the Minister for Community and Social Care, Official Report, column 1307, what the evidential basis is for his statement that the provisions of the Off-patent Drugs Bill would be potentially harmful.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	17208
answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The current legal framework allows a clinician to prescribe drugs outside their licensed indication where that will best meet the clinical needs of their patient. This clinical freedom is crucial in delivering appropriate healthcare to groups of patients for whom medicines have not historically been licensed, e.g. children. It is also helpful in enabling prescribers to quickly pick up and apply new evidence that will help patients with particular clinical needs. The Off-Patent Drugs Bill would introduce a legal duty to apply for a licence for off-patent drugs where evidence of effectiveness for a new indication becomes available. This will create an expectation that only licensed uses of drugs are acceptable and therefore that off-label use is not appropriate. This would cause unnecessary delays in patients getting the medicines they need by slowing the rapid uptake of new evidence in clinical practice. This is why we believe the proposed legislation could potentially be harmful.</p><br /> <br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:45:34 answering member 4020 label Biography information for George Freeman
tabling member	4443 label Biography information for Carol Monaghan

428555

registered interest
date	10/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to improve the availability of off-patent drugs for novel uses through non-legislative measures.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	902130
answer	answer is ministerial correction date of answer 17/11/2015 answer text <p>Clinicians can already prescribe off-patent drugs off-label on clinical grounds if they judge this is the right thing to do to meet the individual clinical needs of their patients.</p><br /><p>The Government is keen to accelerate the adoption of innovative medicines and increase the innovative use of existing medicines where the evidence reports clinical benefits and cost effectiveness to patients. To that end, we are seeking a number of initiatives to provide innovation but whilst supporting the aims of the Private Member’s Bill on this subject, we do not believe the proposed mechanism is either practicable and desirable.</p><br /><p>We are working with NHS England, the National Institute for Health and Care Excellence, the General Medical Council and the Medicines and Health products Regulatory Agency to ensure that there is better information available to support clinicians who wish to prescribe off-patent drugs for off-label indications, and to ensure that new evidence is picked up more quickly and reliably and translated into clinical practice and can be fed through into licensing applications.</p><br /><p>A huge amount of work is also going on in the Accelerated Access Review which will support the “pull” of innovation through to clinical practice.</p><br /><p>As part of the debate on the Access to Medical Treatments Bill, we are working with officials in the Department, the Medicines and Healthcare products Regulatory Agency, and the Health and Social Care Information Centre to see how the power in the Bill, if it were to pass, could address the lack of provision of information on new uses for existing medicines via the power to create a database of innovations in order to support evidence-based prescribing.</p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 902127 question first answered 17/11/2015 17:20:22 answering member 4020 label Biography information for George Freeman
tabling member	4443 label Biography information for Carol Monaghan

173272

registered interest
date	07/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of social care budget changes on A&E attendances.
tabling member constituency	Glasgow North West
tabling member printed	John Robertson
uin	906970
answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>There has been no assessment made of the effect of social care budget changes on accident and emergency (A&amp;E) attendances. However, the Government has legislated to establish the Better Care Fund from 2015-16 to provide better integrated care. One of the conditions of the Better Care Fund is to improve the delivery of health and social care by preventing people reaching crisis point, and to reduce the quantity of non-elective admissions to acute care, which may serve to ease the pressures on A&amp;E departments.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 13/01/2015 15:13:07 answering member 1439 label Biography information for Norman Lamb
tabling member	605 label Biography information for John Robertson

168976

registered interest
date	08/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Poultry Meat
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that consumers are protected from high levels of campylobacter in poultry.
tabling member constituency	Glasgow North West
tabling member printed	John Robertson
uin	906573
answer	answer is ministerial correction date of answer 11/12/2014 answer text <p>The United Kingdom Food Standards Agency (FSA) is working in partnership with industry to tackle <em>Campylobacter</em>, exploring a range of interventions targeted at different points in the food chain to reduce contamination levels before the meat reaches the consumer. Also, in publishing the quarterly results of its UK-wide microbiological survey of <em>Campylobacter</em> contamination in fresh whole chilled chickens at retail sale, the FSA is maintaining consumer awareness of the issue and encouraging retailer action.</p><p> </p><p> </p><p> </p><p>The FSA has provided guidance for consumers on the safety measures that they can take to reduce their risk of spreading and contracting <em>Campylobacter</em> from raw poultry in the home and this featured in its Food Safety Week campaign earlier in the year.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2014 16:19:51 answering member 3918 label Biography information for Jane Ellison
tabling member	605 label Biography information for John Robertson

79393

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding his Department has allocated to research into motor neurone disease in each of last 10 years.
tabling member constituency	Glasgow North West
tabling member printed	John Robertson
uin	206942
answer	answer is ministerial correction date of answer 03/09/2014 answer text <p> </p><p>Prior to the establishment of the National Institute for Health Research (NIHR) in April 2006, the main part of the Department's total health research expenditure was devolved to and managed by national health service organisations. From April 2006 to March 2009, transitional research funding was allocated to these organisations at reducing levels. The organisations have accounted for their use of the allocations they have received from the Department in an annual research and development report. The reports identify total, aggregated expenditure on national priority areas but do not provide details of spend on research into specific diseases including motor neurone disease (MND).</p><p> </p><p> </p><p> </p><p>Expenditure on MND research by the NIHR from 2009-10 through research programmes, research centres and units, and research fellowships is shown in the following table.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Total spend by the NIHR on MND research is higher than this because expenditure by the NIHR Clinical Research Network (CRN) on this topic cannot be disaggregated from total CRN expenditure.</p><p> </p><p> </p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health (Jeremy Hunt) has had no discussions on funding for MND research with the Scottish Government Cabinet Secretary for Health and Wellbeing.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 206931 question first answered 03/09/2014 14:35:42 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	605 label Biography information for John Robertson

79398

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has had with the Cabinet Secretary for Health and Wellbeing in Scotland on funding for research into motor neurone disease.
tabling member constituency	Glasgow North West
tabling member printed	John Robertson
uin	206931
answer	answer is ministerial correction date of answer 03/09/2014 answer text <p> </p><p>Prior to the establishment of the National Institute for Health Research (NIHR) in April 2006, the main part of the Department's total health research expenditure was devolved to and managed by national health service organisations. From April 2006 to March 2009, transitional research funding was allocated to these organisations at reducing levels. The organisations have accounted for their use of the allocations they have received from the Department in an annual research and development report. The reports identify total, aggregated expenditure on national priority areas but do not provide details of spend on research into specific diseases including motor neurone disease (MND).</p><p> </p><p> </p><p> </p><p>Expenditure on MND research by the NIHR from 2009-10 through research programmes, research centres and units, and research fellowships is shown in the following table.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Total spend by the NIHR on MND research is higher than this because expenditure by the NIHR Clinical Research Network (CRN) on this topic cannot be disaggregated from total CRN expenditure.</p><p> </p><p> </p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health (Jeremy Hunt) has had no discussions on funding for MND research with the Scottish Government Cabinet Secretary for Health and Wellbeing.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 206942 question first answered 03/09/2014 14:35:42 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	605 label Biography information for John Robertson